$SPY

Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift

Gotham Asset Management's Q2 2026 13F filing revealed a defensive shift, with a $2.65B increase in SPDR S&P 500 ETF (SPY) holdings, now 20% of its portfolio. The firm also added positions in Humana (HUM), General Mills (GIS), Vornado Realty Trust (VNO), and KLA Corporation (KLAC), focusing on defensive sectors and market beta. Humana showed 26.2% revenue growth, while General Mills offers a 6.22% yield. Vornado's Manhattan office occupancy improved to 92.2%.

Original reporting
Published Aug 18, 2026, 3:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 6:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift — source image
Decision brief

The 30-second read

$SPYNeutralLow
01

Why it matters

For traders, the actionable signal is primarily positioning and factor-tilt sentiment (index beta, staples, managed care, and selective cyclicals). It is not a direct fundamental catalyst like earnings, guidance, or a deal.

02

Market read

This is a 13F-driven positioning narrative that may influence relative sentiment and hedging behavior, but it lacks a new company-specific catalyst.

03

What to watch

The article does not specify whether the adds are new buys versus averaging into existing positions, nor does it provide the filing date relative to market moves or any subsequent company-specific updates.

Relevance 4/10Novelty 3/10Timing: after-hours/next-session positioning read from Gotham’s mid-August Q2 2026 13F

Background

The piece summarizes Gotham Asset Management’s Q2 2026 13F (filed mid-August) and interprets it as a defensive tilt using Greenblatt’s “magic formula” framing.

Company-level read

Ticker impact

$SPYNeutralMedium confidence
Context

Gotham’s 13F adds about $2.65B to SPY, making the ETF a ~20% anchor of its 1,791-position book.

Expected impact

Likely limited direct price impact; more relevant for relative flows and hedging behavior.

Evidence & confidence

The article is a 13F-based positioning read, not a new SPY product, policy, or earnings catalyst.

$HUMBullishMedium confidence
Context

Gotham grew Humana’s share count roughly 65-fold and cites Q2 revenue growth of 26.2% YoY plus a 2028 margin target.

Expected impact

Moderately positive bias for sentiment, but magnitude depends on whether the market already priced the 13F narrative.

Evidence & confidence

The text provides specific operating metrics and a margin target, but the disclosure is still a portfolio filing rather than new company guidance.

$GISBullishMedium confidence
Context

Gotham increased General Mills shares about 4.4x, framing it as a value and yield play with forward P/E 13 and 6.22% yield.

Expected impact

Small-to-moderate positive sentiment effect; not a standalone catalyst for a large repricing.

Evidence & confidence

The article’s novelty is the size of the 13F add and the valuation framing, not a new earnings or guidance print.

$VNOBullishLow confidence
Context

Gotham added Vornado Realty Trust about 3.2x, citing Manhattan office occupancy rising to 92.2% and leasing volume at a 25-year high.

Expected impact

Potentially positive for near-term positioning, but office-cycle sensitivity limits conviction.

Evidence & confidence

The article attributes occupancy and leasing commentary but does not provide a new VNO transaction, guidance, or financing event.

$KLACNeutralLow confidence
Context

Gotham’s KLA add is the outlier at about 8.5x, with the article citing 42.5% operating margins and 87.5% ROE.

Expected impact

Limited direct impact; more relevant as a positioning signal than a new fundamental catalyst.

Evidence & confidence

The text provides profitability metrics but no new order, guidance, or regulatory event.

Market effects

Reinforces a defensive rotation narrative into managed care and staples, while still keeping selective exposure to AI/semi capex and office recovery.

Highlights Manhattan office recovery as a specific read-through for office REIT sentiment.

Mostly US-centric positioning; any global impact is indirect via risk appetite and sector factor rotation.

Counterpoint

A 13F is backward-looking and can reflect tax, rebalancing, or model changes rather than a fresh, time-sensitive thesis; price impact may be overstated.

Key entities

  • Gotham Asset Management

    Reported Q2 2026 13F portfolio changes interpreted as a defensive shift.

  • SPDR S&P 500 ETF Trust

    SPY is described as the centerpiece allocation in Gotham’s book.

  • Humana

    HUM is highlighted as the largest individual conviction add with cited operating momentum and a 2028 margin target.

  • General Mills

    GIS is highlighted as a staples/value and yield conviction add.

  • Vornado Realty Trust

    VNO is highlighted via Manhattan occupancy and leasing-volume recovery commentary.

Related articles

$KLACMedAI 8/10

KLA Gains From Advanced Packaging: Can it Outpace ONTO & AMAT?

KLA (KLAC) is seeing growth in advanced packaging due to AI and HPC chip demand, expecting $1.1B in 2026 revenue. Competitors Onto Innovation (ONTO) and Applied Materials (AMAT) are also expanding in this sector. KLAC's stock is up 50.9% YTD, with a forward P/S of 13.05X. Analysts estimate 2027 earnings at $5.43 per share, up 7.1% in 30 days.

$KLACHighAI 8/10

Is Wall Street Bullish or Bearish on KLA Corporation Stock?

KLA Corporation (KLAC) reported strong Q4 2026 results with revenue up 15.1% to $3.66B and adjusted EPS of $1.05, beating estimates. The company's Q1 2027 guidance also exceeded consensus. Shares have surged 110.9% over 52 weeks, outperforming the S&P 500. Analysts expect 44.2% EPS growth for FY 2027, with a consensus 'Moderate Buy' rating and a mean price target of $237.81.

$UNHHighAI 8/10

Health Insurer Stocks Are Soaring As Companies Get A Handle On Costs

UnitedHealth Group reported $5B in Q2 net income, with a declining medical care ratio. Shares of UnitedHealth, CVS Health, Centene, and Humana have risen significantly. Centene and Humana reported strong earnings, while Humana plans to exit some markets in 2027. Oscar Health entered new markets and saw its stock triple in six months.

$VNOMed

Vornado Realty Trust (VNO) Lands 350 Park Avenue Venture As Valuation Debate Stays Open

Vornado Realty Trust (VNO) has partnered with Rudin Management and a Kenneth C. Griffin affiliate to develop a 1.9M sq ft office tower at 350 Park Avenue. VNO's share price is $37.88, down 4.63% in the past month but up 15.84% over 90 days. Analysts' consensus price target is $36.08, with estimates ranging from $28.0 to $45.0. A DCF model suggests a fair value of $53.08, indicating a 28.6% undervaluation.

$KLACHighAI 9/10

KLA Corporation: See What Wall Street Sees

KLA Corporation (KLAC) dropped 14% in a month despite strong market position and raised revenue guidance. The company reported Q4 revenue of $3.66B, up 15% YoY, and raised its 2026 outlook. CEO Rick Wallace sold 87,568 shares. The stock trades at a 34 forward P/E, with concerns around China export controls and insider sales.